FBLG (FibroBiologics) Pretax Margin %: % (As of Mar. 2026)


FBLG FibroBiologics Inc FBLG
13 GF Score
Price $0.84
! 3 Warning Signs
View Full Analysis

What is FibroBiologics Pretax Margin %?

FibroBiologics FBLG +11.79% 13 Pretax Margin % is % as of Mar. 2026. GuruFocus rates FBLG with a GF Score™ of 13/100. The stock has 3 warning signs investors should review. Among 946 Biotechnology companies, FibroBiologics ranks worse than 105708.14% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. FibroBiologics's Pre-Tax Income for the three months ended in Mar. 2026 was $-5.00 Mil. FibroBiologics's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, FibroBiologics's pretax margin for the quarter that ended in Mar. 2026 was %.

The historical rank and industry rank for FibroBiologics's Pretax Margin % or its related term are showing as below:


FBLG's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -90.5
* Ranked among companies with meaningful Pretax Margin % only.

FibroBiologics  (NAS:FBLG) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

FibroBiologics Pretax Margin % Related Terms

FibroBiologics Pretax Margin % Historical Data

* Premium members only.

The historical data trend for FibroBiologics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FibroBiologics Pretax Margin % Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Pretax Margin %
0.00 0.00 0.00 0.00 0.00

FibroBiologics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FBLG vs BGMS, AIM, APVO: Pretax Margin % Comparison

For the Biotechnology subindustry, FibroBiologics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

FibroBiologics Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FibroBiologics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where FibroBiologics's Pretax Margin % falls into.


FBLG
13GF Score
FibroBiologics Inc FBLG
Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

FibroBiologics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

FibroBiologics's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-18.646/0
= %

FibroBiologics's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-5/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
FibroBiologics (FBLG) has a Pretax Margin % of % as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on FibroBiologics and its competitors. According to the industry distribution chart, FibroBiologics ranks #999999 out of 946 companies in the Biotechnology industry.
Is FibroBiologics' Pretax Margin % too high?
FibroBiologics' current Pretax Margin % is %. Based on the distribution chart, FibroBiologics ranks #999999 out of 946 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, FibroBiologics has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does FibroBiologics' Pretax Margin % compare to BGMS and AIM?
According to the Biotechnology industry distribution chart, FibroBiologics ranks #999999 out of 946 companies for Pretax Margin %. This places FibroBiologics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on FibroBiologics and its competitors. FibroBiologics's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FibroBiologics stock overvalued right now?
FibroBiologics (FBLG) has a current Pretax Margin % of %. The current Pretax Margin % is %. FibroBiologics' overall GF Score™ is 13/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For FibroBiologics (FBLG), the current Pretax Margin % is % as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

FibroBiologics Business Description

Address 455 East Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
13GF Score

Get the complete analysis for FBLG

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.84
Price